Pulmonary interstitial Glycogenosis – a systematic analysis of new cases

E. Seidl (Munich, Germany), J. Carlens (Hannover, Germany), S. Reu (Munich, Germany), M. Wetzke (Hannover, Germany), J. Ley-Zaporozhan (Munich, Germany), F. Brasch (Munich, Germany), W. Wesselak (Munich, Germany), A. Schams (Munich, Germany), D. Rauch (Munich, Germany), L. Schuch (Munich, Germany), M. Kappler (Munich, Germany), P. Schelstraete (Munich, Belgium), M. Wolf (Hamburg, Germany), F. Stehling (Essen, Germany), E. Haarmann (Amsterdam, Netherlands), D. Borensztajn (Amsterdam, Netherlands), M. Van De Loo (Amsterdam, Netherlands), S. Rubak (Aarhus, Denmark), B. Hinrichs (Munich, Germany), N. Schwerk (Hannover, Germany), M. Griese (Munich, Germany)

Source: International Congress 2018 – Progress in rare interstitial lung diseases
Session: Progress in rare interstitial lung diseases
Session type: Oral Presentation
Number: 3787
Disease area: Paediatric lung diseases

Congress or journal article abstractWebcastSlide presentation

Abstract

Background:Pulmonary interstitial glycogenosis (PIG) is a rare interstitial lung disease in children. The clinical hallmark is a rapid onset with respiratory distress and hypoxemia shortly after birth in the absence of an infectious cause or a surfactant dysfunction syndrome. The diagnosis can only be made by lung biopsy. The histopathological pattern defining PIG can exist in diffuse or patchy distribution. Only few cases have been reported. Not much is known on clinical features, outcomes, CT imaging and histopathology.

Methods:The clinical course, CT-scans and tissue samples of children diagnosed with PIG were collected and systematically re-analysed by clinicians, radiologists and pathologists all specialized in interstitial lung diseases in children. All data were uploaded into the Kidslungregister for follow up.

Results: 11 children diagnosed with PIG were included in this study. All presented with respiratory distress shortly after birth. More than half of the children were diagnosed with additional abnormalities, especially congenital heart defects. The CT-scan of the lungs showed mainly groundglass opacities, consolidations and septal thickening. Of interest each tissue sample had signs of reduced alveolarization. The prognosis was favourable in almost all cases. When systemic glucocorticosteroids were given a fast improvement was noticed.

Conclusion: PIG is a interstitial lung disease in infants with mostly favourable outcome. As alveolar growth retardation was present in all subjects this can support a theory of an underlying maturation delay. In all infants with congenital heart defects and unexplained respiratory distress an interstitial lung disease due to PIG should be considered.



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Seidl (Munich, Germany), J. Carlens (Hannover, Germany), S. Reu (Munich, Germany), M. Wetzke (Hannover, Germany), J. Ley-Zaporozhan (Munich, Germany), F. Brasch (Munich, Germany), W. Wesselak (Munich, Germany), A. Schams (Munich, Germany), D. Rauch (Munich, Germany), L. Schuch (Munich, Germany), M. Kappler (Munich, Germany), P. Schelstraete (Munich, Belgium), M. Wolf (Hamburg, Germany), F. Stehling (Essen, Germany), E. Haarmann (Amsterdam, Netherlands), D. Borensztajn (Amsterdam, Netherlands), M. Van De Loo (Amsterdam, Netherlands), S. Rubak (Aarhus, Denmark), B. Hinrichs (Munich, Germany), N. Schwerk (Hannover, Germany), M. Griese (Munich, Germany). Pulmonary interstitial Glycogenosis – a systematic analysis of new cases. 3787

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis
Source: International Congress 2019 – Medical education
Year: 2019

Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review
Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020
Year: 2021



Pulmonary interstitial glycogenosis: Diagnosis and follow-up
Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Year: 2016


Transbronchial pulmonary criobiopsy’s relevance in the diagnostic approach of diffuse pulmonary diseases- Data analysis of the initial learning curve
Source: International Congress 2016 – IPF clinical
Year: 2016



Surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis: a systematic review
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

LATE-BREAKING ABSTRACT: Role of trans-bronchial lung cryobiopsies in interstitial lung diseases: Preliminary results of a Belgian prospective study
Source: International Congress 2016 – IPF clinical
Year: 2016

6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations
Source: International Congress 2014 – ILDs 6
Year: 2014


Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis?
Source: International Congress 2014 – ILDs 1
Year: 2014


Treatment dilemmas in sarcoidosis - a retrospective cohort study
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015


Can current guidelines improve the diagnosis of a usual interstitial pneumonia among general radiologists?
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Comparison of densitometric and visual scoring in the assessment of severity of idiopathic fibrotic interstitial pneumonias: Preliminary observations
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


A multicenter evaluation of a new periostin detection kit for idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Source: Eur Respir J 2015; 46: 1113-1130
Year: 2015



CPFE (combined pulmonary fibrosis and emphysema): A case series
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Pulmonary sequestrations: a review of 7 cases
Source: Eur Respir J 2007; 30: Suppl. 51, 568s
Year: 2007

Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013